DGAT1 level elevated in multiple cancer, such as bladder cancer, myeloma, pancreatic adenocarcinoma, papillary renal cell carcinoma, ovarian cancer, and gastric cancer (Fig. 1a). This evidence concerns the gene DGAT1 and plasma cell myeloma.